| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.44 | 0.009 | 0.447 | Sodium/bile acid cotransporter inhibitor | 0.426 0.011 DBMET00307 0.447 0.008 DBMET01791 0.407 0.015 DBMET01250 0.431 0.01 DBMET01254 0.405 0.015 DBMET01251 0.391 0.02 DBMET01253 0.388 0.021 DBMET01252 | DBMET01791 | |
| 0.42 | 0.052 | 0.42 | Toll-Like receptor 7 agonist | 0.23 0.167 DBMET00307 0.416 0.054 DBMET01791 0.416 0.054 DBMET01254 | ||
| 0.413 | 0.055 | 0.413 | Toll-Like receptor agonist | 0.222 0.177 DBMET00307 0.409 0.057 DBMET01791 0.409 0.057 DBMET01254 | ||
| 0.231 | 0.005 | 0.231 | Leukotriene antagonist | 0.148 0.01 DBMET00307 0.217 0.005 DBMET01791 0.145 0.011 DBMET01250 0.141 0.011 DBMET01254 0.126 0.014 DBMET01251 0.077 0.034 DBMET01253 0.081 0.031 DBMET01252 | ||
| 0.345 | 0.142 | 0.406 | Apoptosis agonist | 0.406 0.111 DBMET00307 0.393 0.117 DBMET01791 0.346 0.141 DBMET01250 0.343 0.143 DBMET01254 0.324 0.156 DBMET01251 0.32 0.158 DBMET01253 0.393 0.117 DBMET01252 | DBMET00307 | |
| 0.176 | 0.004 | 0.209 | Bcl2 antagonist | 0.152 0.005 DBMET00307 0.164 0.005 DBMET01791 0.209 0.004 DBMET01250 0.186 0.004 DBMET01254 0.195 0.004 DBMET01251 0.207 0.004 DBMET01253 0.171 0.005 DBMET01252 | DBMET01250 | |
| 0.15 | 0.005 | 0.15 | Leukotriene D4 antagonist | 0.111 0.005 DBMET00307 0.123 0.005 DBMET01791 0.122 0.005 DBMET01250 0.132 0.005 DBMET01254 0.115 0.005 DBMET01251 0.088 0.006 DBMET01253 0.073 0.007 DBMET01252 | ||
| 0.275 | 0.18 | 0.441 | Calcium channel L-type activator | 0.279 0.175 DBMET00307 0.248 0.207 DBMET01791 0.342 0.123 DBMET01250 0.416 0.071 DBMET01254 0.301 0.157 DBMET01251 0.441 0.056 DBMET01253 0.309 0.15 DBMET01252 | DBMET01253 | |
| 0.101 | 0.006 | 0.14 | Bcl-xL inhibitor | 0.085 0.009 DBMET00307 0.095 0.007 DBMET01791 0.14 0.004 DBMET01250 0.101 0.006 DBMET01254 0.129 0.004 DBMET01251 0.13 0.004 DBMET01253 0.111 0.005 DBMET01252 | DBMET01250 | |
| 0.169 | 0.074 | 0.248 | Mcl-1 antagonist | 0.131 0.111 DBMET00307 0.147 0.092 DBMET01791 0.248 0.037 DBMET01250 0.16 0.08 DBMET01254 0.231 0.042 DBMET01251 0.223 0.045 DBMET01253 0.176 0.069 DBMET01252 | DBMET01250 | |
| 0.109 | 0.031 | 0.123 | Bromodomain-containing protein 2 inhibitor | 0.123 0.021 DBMET01250 0.123 0.021 DBMET01251 0.081 0.075 DBMET01253 | DBMET01251 | |
| 0.085 | 0.018 | 0.09 | Prostaglandin E2 antagonist | 0.055 0.031 DBMET00307 0.09 0.017 DBMET01791 0.089 0.017 DBMET01250 0.078 0.02 DBMET01254 0.09 0.017 DBMET01251 0.081 0.019 DBMET01253 0.056 0.031 DBMET01252 | DBMET01251 | |
| 0.106 | 0.054 | 0.123 | Platelet activating factor alpha antagonist | 0.081 0.079 DBMET01791 0.123 0.043 DBMET01254 | DBMET01254 | |
| 0.161 | 0.116 | 0.161 | Platelet aggregation inhibitor | 0.154 0.124 DBMET01791 0.158 0.119 DBMET01254 | ||
| 0.206 | 0.162 | 0.266 | Angiogenesis inhibitor | 0.232 0.137 DBMET00307 0.205 0.163 DBMET01791 0.203 0.166 DBMET01250 0.226 0.142 DBMET01254 0.236 0.134 DBMET01251 0.263 0.113 DBMET01253 0.266 0.112 DBMET01252 | DBMET01252 | |
| 0.07 | 0.028 | 0.079 | Kallikrein 7 inhibitor | 0.062 0.05 DBMET00307 0.065 0.04 DBMET01791 0.075 0.02 DBMET01250 0.07 0.029 DBMET01254 0.079 0.015 DBMET01251 0.079 0.015 DBMET01253 0.07 0.028 DBMET01252 | DBMET01253 | |
| 0.235 | 0.196 | 0.235 | Analgesic | |||
| 0.044 | 0.008 | 0.048 | HCV polyprotein inhibitor | 0.046 0.007 DBMET00307 0.041 0.011 DBMET01791 0.048 0.006 DBMET01254 0.033 0.025 DBMET01253 0.033 0.026 DBMET01252 | DBMET01254 | |
| 0.12 | 0.084 | 0.167 | Sodium channel blocker | 0.167 0.046 DBMET01250 0.118 0.086 DBMET01251 | DBMET01250 | |
| 0.096 | 0.069 | 0.098 | Bronchodilator | 0.098 0.067 DBMET01791 0.095 0.07 DBMET01254 | DBMET01791 | |
| 0.116 | 0.089 | 0.166 | Sodium channel (voltage-gated) blocker | 0.166 0.044 DBMET01250 0.135 0.068 DBMET01251 0.106 0.102 DBMET01253 | DBMET01250 | |
| 0.054 | 0.027 | 0.058 | Bromodomain-containing protein 3 inhibitor | 0.047 0.039 DBMET01791 0.058 0.023 DBMET01250 0.053 0.028 DBMET01251 | DBMET01250 | |
| 0.128 | 0.104 | 0.146 | Phospholipase A2 inhibitor | 0.146 0.078 DBMET01250 0.137 0.09 DBMET01251 0.119 0.118 DBMET01253 0.119 0.118 DBMET01252 | DBMET01250 | |
| 0.119 | 0.096 | 0.285 | Vascular endothelial growth factor 3 antagonist | 0.194 0.044 DBMET00307 0.179 0.05 DBMET01250 0.129 0.086 DBMET01254 0.187 0.047 DBMET01251 0.205 0.04 DBMET01253 0.285 0.021 DBMET01252 | DBMET01252 | |
| 0.057 | 0.034 | 0.065 | Prostaglandin antagonist | 0.059 0.032 DBMET01791 0.062 0.03 DBMET01250 0.048 0.041 DBMET01254 0.065 0.029 DBMET01251 0.055 0.035 DBMET01253 0.048 0.041 DBMET01252 | DBMET01251 | |
| 0.043 | 0.042 | 0.05 | Carnitine palmitoyltransferase 1B inhibitor | 0.049 0.031 DBMET01250 0.05 0.029 DBMET01251 0.046 0.037 DBMET01253 0.049 0.03 DBMET01252 | DBMET01251 | |
| 0.025 | 0.026 | 0.035 | Prostaglandin EP3 antagonist | 0.03 0.021 DBMET01791 0.035 0.017 DBMET01250 0.035 0.017 DBMET01251 | DBMET01251 | |
| 0.076 | 0.078 | 0.09 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.09 0.063 DBMET01254 | DBMET01254 | |
| 0.046 | 0.049 | 0.059 | Carbonic anhydrase II stimulant | 0.056 0.029 DBMET01250 0.05 0.039 DBMET01254 0.054 0.031 DBMET01251 0.059 0.024 DBMET01253 0.052 0.035 DBMET01252 | DBMET01253 | |
| 0.04 | 0.047 | 0.052 | Mineralocorticoid receptor antagonist | 0.052 0.028 DBMET01254 0.048 0.033 DBMET01253 | DBMET01254 | |
| 0.065 | 0.074 | 0.099 | Somatostatin 1 agonist | 0.099 0.034 DBMET01254 0.096 0.037 DBMET01253 | DBMET01254 | |
| 0.18 | 0.19 | 0.234 | MAP kinase kinase 3 inhibitor | 0.234 0.051 DBMET01250 0.185 0.171 DBMET01254 0.192 0.148 DBMET01251 0.198 0.127 DBMET01253 | DBMET01250 | |
| 0.029 | 0.04 | 0.055 | Carbonic anhydrase I stimulant | 0.044 0.02 DBMET01250 0.038 0.026 DBMET01254 0.041 0.023 DBMET01251 0.055 0.014 DBMET01253 0.04 0.024 DBMET01252 | DBMET01253 | |
| 0.028 | 0.04 | 0.037 | Farnesoid X receptor agonist | 0.037 0.027 DBMET01791 | DBMET01791 | |
| 0.045 | 0.056 | 0.057 | Bromodomain-containing protein 4 inhibitor | 0.057 0.036 DBMET01250 0.051 0.044 DBMET01251 | DBMET01250 | |
| 0.015 | 0.027 | 0.018 | Progesterone receptor B antagonist | 0.018 0.017 DBMET01253 | DBMET01253 | |
| 0.087 | 0.099 | 0.128 | Nav1.4 sodium channel blocker | 0.096 0.083 DBMET01250 0.117 0.055 DBMET01254 0.096 0.082 DBMET01251 0.128 0.045 DBMET01253 0.096 0.083 DBMET01252 | DBMET01253 | |
| 0.013 | 0.025 | 0.017 | CC chemokine 10 receptor antagonist | 0.014 0.013 DBMET00307 0.017 0.007 DBMET01250 0.015 0.011 DBMET01253 0.016 0.009 DBMET01252 | DBMET01250 | |
| 0.041 | 0.054 | 0.045 | HCV NS3/NS4A protease inhibitor | 0.045 0.042 DBMET01254 | DBMET01254 | |
| 0.02 | 0.034 | 0.034 | Glucocorticoid antagonist | 0.034 0.022 DBMET01254 | DBMET01254 | |
| 0.02 | 0.034 | 0.032 | Endothelin receptor antagonist | 0.031 0.017 DBMET01250 0.028 0.019 DBMET01251 0.032 0.016 DBMET01253 0.026 0.022 DBMET01252 | DBMET01253 | |
| 0.014 | 0.029 | 0.022 | Endothelin A receptor antagonist | 0.021 0.015 DBMET01250 0.019 0.017 DBMET01251 0.022 0.014 DBMET01253 | DBMET01253 | |
| 0.05 | 0.068 | 0.091 | Prostaglandin F2 alpha antagonist | 0.091 0.015 DBMET01791 | DBMET01791 | |
| 0.039 | 0.071 | 0.059 | Elastase inhibitor | 0.058 0.032 DBMET00307 0.059 0.031 DBMET01252 | DBMET01252 | |
| 0.084 | 0.12 | 0.126 | Nav1.5 sodium channel blocker | 0.126 0.047 DBMET01250 0.098 0.09 DBMET01251 | DBMET01250 | |
| 0.013 | 0.054 | 0.022 | CYP24 inhibitor | 0.022 0.017 DBMET01791 | DBMET01791 | |
| 0.047 | 0.089 | 0.064 | ZAP-70 protein tyrosine kinase inhibitor | 0.064 0.056 DBMET01250 | DBMET01250 | |
| 0.127 | 0.169 | 0.167 | Cyclin-dependent kinase 3 inhibitor | 0.138 0.13 DBMET01250 0.167 0.064 DBMET01251 0.156 0.083 DBMET01253 | DBMET01251 | |
| 0.112 | 0.157 | 0.126 | Pregnane X receptor agonist | 0.126 0.11 DBMET01251 | DBMET01251 | |
| 0.081 | 0.132 | 0.127 | Bone formation stimulant | 0.127 0.079 DBMET01791 | DBMET01791 | |
| 0.161 | 0.214 | 0.284 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.284 0.076 DBMET01250 0.258 0.099 DBMET01251 | DBMET01250 | |
| 0.128 | 0.193 | 0.249 | Histone acetyltransferase inhibitor | 0.249 0.026 DBMET01250 0.156 0.131 DBMET01254 0.186 0.09 DBMET01251 0.209 0.056 DBMET01253 | DBMET01250 | |
| 0.029 | 0.11 | 0.126 | 5 Hydroxytryptamine 6 antagonist | 0.126 0.009 DBMET01250 0.063 0.034 DBMET01251 0.055 0.042 DBMET01253 | DBMET01250 | |
| 0.066 | 0.156 | 0.159 | Tubulin antagonist | 0.132 0.07 DBMET00307 0.104 0.097 DBMET01250 0.159 0.054 DBMET01252 | DBMET01252 | |
| 0.194 | 0.284 | 0.269 | Cyclophilin D inhibitor | 0.269 0.192 DBMET01791 | DBMET01791 | |
| 0.042 | 0.159 | 0.081 | Adrenaline agonist | 0.081 0.056 DBMET01254 | DBMET01254 | |
| 0.028 | 0.154 | 0.048 | 5 Hydroxytryptamine 1B agonist | 0.048 0.047 DBMET01253 | DBMET01253 | |
| 0.057 | 0.185 | 0.108 | Cyclooxygenase 2 inhibitor | 0.108 0.094 DBMET01250 0.103 0.1 DBMET01253 | DBMET01250 | |
| 0.057 | 0.221 | 0.115 | Cyclooxygenase inhibitor | 0.115 0.106 DBMET01250 | DBMET01250 | |
| 0.094 | 0.26 | 0.144 | Lipocortins synthesis antagonist | 0.144 0.115 DBMET01250 | DBMET01250 | |
| 0.01 | 0.18 | 0.094 | Beta tubulin antagonist | 0.061 0.039 DBMET00307 0.094 0.024 DBMET01252 | DBMET01252 | |
| 0.034 | 0.211 | 0.066 | HIV-1 integrase inhibitor | 0.066 0.055 DBMET01252 | DBMET01252 | |
| 0.015 | 0.204 | 0.054 | HIV-1 integrase (Strand Transfer) inhibitor | 0.054 0.046 DBMET01252 | DBMET01252 | |
| 0.054 | 0.262 | 0.15 | NADPH oxidase inhibitor | 0.15 0.054 DBMET01250 0.121 0.082 DBMET01251 0.136 0.066 DBMET01253 | DBMET01250 | |
| 0.02 | 0.254 | 0.061 | Cyclin D1 inhibitor | 0.061 0.042 DBMET01250 0.057 0.047 DBMET01251 0.055 0.051 DBMET01253 | DBMET01250 | |
| 0.086 | 0.327 | 0.341 | Thyroid hormone beta antagonist | 0.184 0.17 DBMET01250 0.341 0.072 DBMET01251 0.238 0.126 DBMET01253 | DBMET01251 | |
| 0.062 | 0.304 | 0.16 | Antimitotic | 0.16 0.112 DBMET00307 0.155 0.117 DBMET01252 | DBMET00307 | |
| 0.082 | 0.337 | 0.386 | Thyroid hormone antagonist | 0.181 0.178 DBMET01250 0.331 0.081 DBMET01251 0.227 0.139 DBMET01253 0.386 0.06 DBMET01252 | DBMET01252 | |
| 0.086 | 0.35 | 0.178 | Death-associated protein kinase 2 inhibitor | 0.151 0.105 DBMET01251 0.178 0.056 DBMET01253 | DBMET01253 | |
| 0.077 | 0.35 | 0.195 | Lipoxygenase inhibitor | 0.195 0.146 DBMET01250 | DBMET01250 | |
| 0.012 | 0.293 | 0.056 | 5 Hydroxytryptamine 1D antagonist | 0.056 0.053 DBMET01253 | DBMET01253 | |
| 0.046 | 0.333 | 0.1 | Toll-Like receptor 3 antagonist | 0.1 0.051 DBMET01250 | DBMET01250 | |
| 0.055 | 0.343 | 0.387 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.387 0.041 DBMET01250 0.363 0.047 DBMET01251 0.272 0.072 DBMET01253 | DBMET01250 | |
| 0.076 | 0.37 | 0.274 | Alpha-glucosidase inhibitor | 0.274 0.173 DBMET01253 | DBMET01253 | |
| 0.062 | 0.356 | 0.154 | Non-steroidal antiinflammatory agent | 0.154 0.11 DBMET01250 | DBMET01250 | |
| 0.066 | 0.388 | 0.219 | Focal adhesion kinase 2 inhibitor | 0.212 0.061 DBMET01250 0.176 0.092 DBMET01251 0.219 0.056 DBMET01253 | DBMET01253 | |
| 0.099 | 0.432 | 0.175 | Peptidyltransferase inhibitor | 0.175 0.138 DBMET01791 | DBMET01791 | |
| 0.036 | 0.376 | 0.116 | Diuretic | 0.116 0.11 DBMET01252 | DBMET01252 | |
| 0.053 | 0.403 | 0.101 | Interleukin 2 antagonist | 0.101 0.087 DBMET00307 | DBMET00307 | |
| 0.048 | 0.399 | 0.185 | Hexokinase inhibitor | 0.165 0.062 DBMET01250 0.183 0.046 DBMET01251 0.185 0.045 DBMET01253 0.151 0.077 DBMET01252 | DBMET01253 | |
| 0.055 | 0.412 | 0.272 | 5 Hydroxytryptamine 1E antagonist | 0.191 0.142 DBMET01250 0.238 0.088 DBMET01251 0.272 0.052 DBMET01253 | DBMET01253 | |
| 0.015 | 0.372 | 0.072 | Metalloproteinase-2 inhibitor | 0.072 0.062 DBMET01253 | DBMET01253 | |
| 0.059 | 0.419 | 0.383 | DNA polymerase beta inhibitor | 0.244 0.196 DBMET01250 0.383 0.126 DBMET01251 0.313 0.158 DBMET01253 | DBMET01251 | |
| 0.04 | 0.401 | 0.226 | Interleukin antagonist | 0.226 0.071 DBMET01253 0.188 0.091 DBMET01252 | DBMET01253 | |
| 0.014 | 0.391 | 0.054 | Carbonic anhydrase stimulant | 0.054 0.048 DBMET01253 | DBMET01253 | |
| 0.024 | 0.416 | 0.109 | Alkaline phosphatase inhibitor | 0.109 0.102 DBMET01253 | DBMET01253 | |
| 0.05 | 0.453 | 0.217 | Calpain 2 inhibitor | 0.206 0.182 DBMET01251 0.217 0.174 DBMET01253 | DBMET01253 | |
| 0.049 | 0.467 | 0.315 | DNA directed DNA polymerase inhibitor | 0.315 0.155 DBMET01251 | DBMET01251 | |
| 0.03 | 0.473 | 0.234 | Beta lactamase inhibitor | 0.234 0.165 DBMET01251 | DBMET01251 | |
| 0.006 | 0.467 | 0.043 | Dihydrofolate reductase inhibitor | 0.043 0.032 DBMET01250 | DBMET01250 | |
| 0.016 | 0.52 | 0.233 | Aryl hydrocarbon receptor agonist | 0.185 0.111 DBMET01250 0.166 0.124 DBMET01251 0.233 0.086 DBMET01253 | DBMET01253 | |
| 0.02 | 0.595 | 0.167 | Calpain inhibitor | 0.167 0.152 DBMET01253 | DBMET01253 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |